Drugbank Logo

Search Results

Search for "Abacavir" returned 5 results

Showing 1-5 out of 5
DrugBank ID Name Formula Weight
DB01048
DrugCard button for DB01048
Abacavir C14H18N6O 286.3323
... Trizivir (Abacavir Sulfate + Lamivudine + Zidovudine) Abacavir Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1).
DB00709
DrugCard button for DB00709
Lamivudine C8H11N3O3S 229.2560
... Abacavir (Abacavir Sulfate) + Lamivudine) Trizivir (Abacavir (Abacavir Sulfate) + Lamivudine + Zidovudine) Lamivudine Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) with ...
DB00495
DrugCard button for DB00495
Zidovudine C10H13N5O4 267.2413
Combivir (Lamivudine + Zidovudine) Trizivir (Abacavir sulfate + Lamivudine + Zidovudine) Zidovudine Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human ...
DB01610
DrugCard button for DB01610
Valganciclovir C14H22N6O5 354.3617
... of reverse transcriptase inhibitors (nucleoside), such as Abacavir, may be enhanced by Valganciclovir. There is a risk of hematologic toxicity. Diligent monitoring during concomitant therapy ...
DB00932
DrugCard button for DB00932
Tipranavir C31H33F3N2O5S 602.6640
Abacavir Tipranavir decreases the concentration of Abacavir. Alprazolam Tipranavir may decrease the metabolism and clearance of Alprazolam. Consider alternate therapy or monitor for Alprazolam ...
Showing 1-5 out of 5

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.